Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity
February 2010
by Susan Lenderts, BA; Amir H. Kalali, MD; and Richard Weisler, MD
Ms. Lenderts is Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California; and Dr. Weisler is from Duke University Medical Center, Durham, North Carolina, and University of North Carolina at Chapel Hill Departments of Psychiatry, Raleigh, North Carolina.
Psychiatry (Edgemont) 2010;7(2):17–23
This is protected content.
Popularity: 4% [?]
Related posts
- Dysthymic Disorder: Forlorn and Overlooked?
- Treatment of Comorbid Adolescent Cannabis Use and Major Depressive Disorder
- Depression and Coronary Artery Disease: The Association, Mechanisms, and Therapeutic Implications
- Early- versus Late-Onset Dysthymia: A Meaningful Clinical Distinction?
- Adolescent Depression: An Update and Guide to Clinical Decision-Making
- Depression and Cardiovascular Disease: Just an Urban Legend?
- Asthma: Wheezing, Woes, and Worries
- Family Therapy with a Depressed Adolescent
- Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning
Posted in Trend Watch | 1 Comment »
March 2nd, 2010 at 1:43 pm
[...] Analysis of Classes Used in the Treatment of Depression by Physician-reported Severity Popular tagsadolescent Alzheimer’s disease antidepressant antidepressants antipsychotics anxiety benzodiazepine bipolar disorder borderline personality disorder combination therapy comorbidity depression diagnosis ethics monotherapy pain psychiatrist psychiatry psychotherapy PTSD schizophrenia SSRI substance abuse suicide treatment Editor's Message: Issue Highlights [...]